Sign up
Pharma Capital

Massive opportunities for OptiBiotix Health's new and improved SlimBiome

Christina Wood, Sales & Marketing Director for OptiBiotix Health plc (LON:OPTI) and Max Tomlinson, founder and creator of GoFigure, update Proactive's Andrew Scott on the commercial progress being made with SlimBiome.

Slimbiome is their patented combination of natural ingredients which supports scientifically substantiated weight loss claims.

OptiBiotix has recently signed a profit sharing agreement with Knighton Foods, which will manufacture and distribute SlimBiome.

 

View full OPTI profile

OptiBiotix Health plc Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.